A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM)
ACTIVE_NOT_RECRUITING
Status
Conditions
- House Dust Mite Allergy
- House Dust Mite Rhinitis
Interventions
- BIOLOGICAL: PURETHAL Mites 50,000 AUeq/ml
- BIOLOGICAL: Biological/Vaccine: Placebo
Sponsor
HAL Allergy
Collaborators
- [object Object]
- [object Object]